Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

Mirogabalin (DS‐5565) is a novel preferentially selective α(2)δ‐1 ligand being developed for the treatment of diabetic peripheral neuropathic pain and postherpetic neuralgia. The current multicenter open‐label study determined the effect of varying degrees of renal impairment on the pharmacokinetics...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Pharmacol
Asıl Yazarlar: Kato, Manabu, Tajima, Naoyuki, Shimizu, Takako, Sugihara, Masahiro, Furihata, Kenichi, Harada, Kazuhiro, Ishizuka, Hitoshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Special Populations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763271/
https://ncbi.nlm.nih.gov/pubmed/28834546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.974
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller